Sign in
4

Changes in Ownership

Voyager Therapeutics, Inc. Filed Acc 0001104659-22-101960

Options or other derivatives

  • Chief Scientific Officer acquired 165,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Carter Todd Alfred · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-09-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +165,000 $6.18 2032-09-19 165,000 165,000 D
Loading xslF345X03/tm2226340-2_4seq1.xml…